Drug intelligence / Profile preview

ascorbic acid + zinc

Development stage: Unknown
Lead developer: INNventa Pharm
Modality: Small Molecules
Administration: Oral

Overview

IMUNITINN C+Zn is a dietary supplement developed by INNventa Pharm, a pharmaceutical company based in Belgrade, Serbia. It contains a combination of Vitamin C (ascorbic acid) and Zinc, which are essential for the normal functioning of the immune system and the protection of cells from oxidative stress. The product is indicated for general immune support, the prevention of colds, flu, and chronic respiratory infections, as well as the reduction of fatigue and exhaustion. It also supports wound healing and collagen formation. IMUNITINN C+Zn is available in two forms: tablets and 'direct' oral sachets, and is distributed in Serbia and other Central and Eastern European markets.

Brand names: Imunitinn C + ZnImunitinn C + Zn direct
Other names: Vitamin C + Zinc

Beyond the preview

Go deeper on ascorbic acid + zinc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ascorbic acid + zinc.

Explore the full profile